CORRELATION OF ANTITUMOR CHEMOIMMUNOTHERAPY WITH BONE-MARROW MACROPHAGE PRECURSOR CELL STIMULATION AND MACROPHAGE CYTOTOXICITY

  • 1 January 1976
    • journal article
    • research article
    • Vol. 36  (7) , 2241-2247
Abstract
The present investigations assessed the effects of prolonged cyclophosphamide (CY) and Corynebacterium (CP) treatment on the production of bone marrow macrophage precursors [colony-forming cells (CFC)] and the cytotoxicity of macrophages comprising colonies produced by CFC. The findings were correlated with tumor growth in animals receiving immunochemotherapy. Studies were also directed toward ascertaining whether the administration of CP with CY might lessen the myelosuppressive effects of the latter. Following each consecutive weekly dose of CY (even after as many as 11), there was a significant depression in the number of bone marrow cells (BMC''s) but, by the next injection, marrow cellularity returned to normal. When the number of BMC''s was reduced, the proportion of the remaining cells, which consisted of CFC, was increased. On reconstitution of the marrow, the proportion of CFC returned to the level of the controls. The total number of CFC in marrow was at no time following CY therapy significantly less than the number in marrow of untreated [mammary tumor-bearing] mice. The addition of CP to the treatment regimen with CY resulted in an absolute as well as relative increase in CFC at all times during administration of the combined therapy, i.e., when there was a depression in total numbers of marrow cells, as well as when marrow restoration occurred. Although CP stimulated the number of cells entering into differentiation, it failed to effect the total BMC population when given during CY therapy. Numbers of BMC''s were neither increased nor prevented from decreasing, by CP administration, indicating that the use of total cellularity as an index of the CP marrow-sparing effect is without merit. The present results relative to cytotoxicity of macrophages derived from the CFC concur with and extend previous findings indicating that the cytotoxic property of macrophages originates in its ancestral stem cell or CFC and factors responsible for increasing the CFC population do not selectively stimulate precursor cells responsible for production of the cytotoxic macrophage. Although the proportion of cytotoxic macrophages was not altered by CP when administered with CY, the absolute number of such cells was increased. Since the increase in macrophage colony production and, consequently, in cytotoxic macrophages correlates with increased inhibition of tumor growth when CP was used with CY, macrophage precursors are the probable cells of primacy in CP immunopotentiation. Their stimulation, resulting in enhanced cytotoxic macrophage formation, could be responsible for the inhibition of tumor growth observed in this model system. When myelosuppression is a limiting factor in the use of a chemotherapeutic agent, the concomitant use of CP may be advantageous.